Formulation: A 25 mg/ml solution in ethanol
Purity: ≥98%
Formulation: A 5 mg/ml solution in ethanol
Purity: ≥95%
PAF C-
A potent mediator of neutrophil migration and production of ROS
CAS No. 74389-68-7
Item No. 60900
Formulation: A lyophilized powder
Purity: ≥98%
- Platelet-
activating Factor C- 16
Formulation: A 10 mg/ml solution in ethanol
Purity: ≥98%
Formulation: A 10 mg/ml solution in ethanol
Purity: ≥98%
Formulation: A 10 mg/ml solution in ethanol
Purity: ≥98%
Formulation: A 10 mg/ml solution in ethanol
Purity: ≥97%
Formulation: A lyophilized powder
Purity: ≥98%
PAF C-
An internal standard for the quantification of PAF C-
CAS No. 211106-54-6
Item No. 360900
Formulation: A 1 mg/ml solution in ethanol
Purity: ≥99% deuterated forms (d1-d4)
- Platelet-
activating Factor C- 16- d4
Formulation: A lyophilized powder
Purity: ≥98%
Formulation: A lyophilized powder
Purity: ≥98%
Formulation: A 10 mg/ml solution in ethanol
Purity: ≥95%
- 1-Oleyl-2-acetyl-sn-glycero-3-phosphorylcholine
- Platelet-activating Factor C-18:1
Formulation: A lyophilized powder
Purity: ≥98%
Formulation: A 5 mg/ml solution in ethanol
Purity: ≥98%
Formulation: A 1 mg/ml solution in ethanol
Purity: ≥99% deuterated forms (d1-d4)
Formulation: A 5 mg/ml solution in ethanol
Purity: ≥95%
- CPAGP
- Platelet-
activating Factor C- 16 Carboxylic Acid
Formulation: A lyophilized powder
Purity: ≥98%
- Edelfosine
- ET-18-OCH3
- 1-
O- octadecyl- 2- O- methyl- sn- glyceryl- 3- phosphorylcholine
Lyso-
An internal standard for the quantification of Lyso-
CAS No. 201216-37-7
Item No. 360906
Formulation: A 1 mg/ml solution in ethanol
Purity: ≥99% deuterated forms (d1-d4)
- Lyso-
Platelet- activating Factor C- 16- d4
Formulation: A crystalline solid
Purity: ≥99% deuterated forms (d1-d4)
2-
A synthetic PAF analog with an ethyl group at the sn-
CAS No. 78858-42-1
Item No. 60925
Formulation: A lyophilized powder
Purity: ≥98%
Formulation: A 10 mg/ml solution in ethanol
Purity: ≥98%
1-O-hexadecyl-
A PAF analog that contains EPA
CAS No. 132196-28-2
Item No. 60907
Formulation: A 10 mg/ml solution in ethanol
Purity: ≥98%
- 1-O-hexadecyl-2-Eicosapenaenoyl-sn-glycero-3-phosphocholine
- 1-O-hexadecyl-2-Eicosapenaenoyl-sn-glyceryl-phosphocholine
- 1-O-hexadecyl-2-O-Eicosapenaenoyl-sn-glyceryl-PC
- PC(O-16:0/20:5)
1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-3-PC
A PAF analog that contains docosahexaenoate
CAS No. 132213-85-5
Item No. 60903
Formulation: A 10 mg/ml solution in ethanol containing 0.1% BHT
Purity: ≥98%
- 1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-3-phosphocholine
- 1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-phosphocholine
- 1-O-hexadecyl-2-Docosahexaenoyl-sn-glyceryl-phosphocholine
- 1-O-hexadecyl-2-O-Docosahexaenoyl-sn-glycero-PC
- 1-O-hexadecyl-2-O-Docosahexaenoyl-sn-glyceryl-PC
- PC(O-16:0/22:6)
1-O-hexadecyl-
A PAF analog that contains DGLA
CAS No. 155575-01-2
Item No. 60901
Formulation: A 10 mg/ml solution in ethanol containing 0.1% BHT
Purity: ≥98%
- 1-
O- hexadecyl- 2- Dihomo- γ- Linolenoyl- sn- glycero- 3- Phosphocholine - 1-O-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-Phosphocholine
- 1-O-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-Phosphocholine
- 1-O-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glyceryl-Phosphocholine
- 1-O-hexadecyl-2-O-(8Z,11Z,14Z-eicosatrienoyl)-sn-glyceryl-PC
- PC(O-16:0/20:3)
Formulation: A crystalline solid
Purity: ≥95%
- 1-Palmitoyl-2-formylyl Phosphatidylcholine
- PFPC
Contact Info
Cayman Chemical1180 East Ellsworth RoadAnn Arbor, Michigan 48108 USAToll Free: (800) 364-9897(USA and Canada only)Fax: (734) 971-3640
